ReviewNanomaterials (Basel, Switzerland)2023
Nanoparticles, an Emerging Control Method for Harmful Algal Blooms: Current Technologies, Challenges, and Perspectives.
Review in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 23 citations in OpenAlex.
- Nanotechnological applications of marine algae derived neurotoxins spanning harmful algal blooms and therapeutic innovations.Discover nano · 2026Review
- Comparative Genome Analysis of Three Halobacillus Strains Isolated From Saline Environments Reveal Potential Salt Tolerance and Algicidal Mechanisms.Environmental microbiology reports · 2025Article
- Acute Toxicity of Carbon Nanotubes, Carbon Nanodots, and Cell-Penetrating Peptides to Freshwater Cyanobacteria.Toxins · 2025Article
- Bionanotechnology: A Paradigm for Advancing Environmental Sustainability.Indian journal of microbiology · 2025Article
- Removal of cyanobacterial harmful algal blooms (HABs) from contaminated local park lake usingHeliyon · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Harmful algal blooms (HABs) are a global concern because they harm aquatic ecosystems and pose a risk to human health. Various physical, chemical, and biological approaches have been explored to control HABs. However, these methods have limitations in terms of cost, environmental impact, and effectiveness, particularly for large water bodies. Recently, the use of nanoparticles has emerged as a promising strategy for controlling HABs. Briefly, nanoparticles can act as anti-algae agents via several mechanisms, including photocatalysis, flocculation, oxidation, adsorption, and nutrient recovery. Compared with traditional methods, nanoparticle-based approaches offer advantages in terms of environmental friendliness, effectiveness, and specificity. However, the challenges and risks associated with nanoparticles, such as their toxicity and ecological impact, must be considered. In this review, we summarize recent research progress concerning the use of nanoparticles to control HABs, compare the advantages and disadvantages of different types of nanoparticles, discuss the factors influencing their effectiveness and environmental impact, and suggest future directions for research and development in this field. Additionally, we explore the causes of algal blooms, their harmful effects, and various treatment methods, including restricting eutrophication, biological control, and disrupting living conditions. The potential of photocatalysis for generating reactive oxygen species and nutrient control methods using nanomaterials are also discussed in detail. Moreover, the application of flocculants/coagulants for algal removal is highlighted, along with the challenges and potential solutions associated with their use. This comprehensive overview aims to contribute to the development of efficient and sustainable strategies for controlling HAB control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.